BIOBASE Biological Databases Launches PharmacoGenomic Mutation Database (PGMD™) – a Knowledge-base Containing Genetic Variants that Affect Drug Response

BEVERLY, Mass.--(BUSINESS WIRE)--BIOBASE Corporation, the leading provider of expert-curated biological databases, software and services for life science researchers, today announced the release of PGMD™ at the American Society of Human Genetics (ASHG) annual meeting in Boston, MA. PGMD is a database of detailed genotype-phenotype relationships derived from in vivo pharmacogenomic patient studies, stemming mostly from clinical trials, with insights pertaining to response rate, risk of adverse events, realization of expected outcomes (e.g. patient survival), pharmacokinetic parameters such as dose requirements, and much more.

Help employers find you! Check out all the jobs and post your resume.